Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Hepatic Encephalopathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hepatic Encephalopathy (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Hepatic Encephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
96 pages
Sarcopenia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Sarcopenia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
98 pages
Alcohol Addiction - Pipeline Review, H2 2020
US$ 2,000.00
... . The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
180 pages
Nocturia - Pipeline Review, H2 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Nocturia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
45 pages
Diabetic Macular Edema - Pipeline Review, H2 2020
US$ 2,000.00
... . The Diabetic Macular Edema (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
319 pages
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
218 pages
Traumatic Brain Injury - Pipeline Review, H2 2020
US$ 2,000.00
... . The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
440 pages
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Traumatic Stress Disorder (PTSD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
195 pages
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Reflux Esophagitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Reflux Esophagitis (Gastro esophageal Reflux Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
113 pages
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Acute Respiratory Distress Syndrome (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Acute Respiratory Distress Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
667 pages
Alopecia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
222 pages
Amyloidosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Amyloidosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Amyloidosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
241 pages
Anthrax - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
126 pages
Diarrhea - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
156 pages
Fatigue - Pipeline Review, H2 2020
US$ 2,000.00
... . The Fatigue (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
37 pages
Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
80 pages
Restless Legs Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... . The Restless Legs Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Restless Legs Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
63 pages
Smallpox - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Smallpox (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
85 pages
Birch Pollen Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Birch Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Birch Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
38 pages
Lyme Disease - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Lyme Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
64 pages
Myasthenia Gravis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Myasthenia Gravis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Myasthenia Gravis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
254 pages
Obsessive-Compulsive Disorder - Pipeline Review, H2 2020
US$ 2,000.00
... . The Obsessive-Compulsive Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Obsessive-Compulsive Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
60 pages
Thromboembolism - Pipeline Review, H2 2020
US$ 2,000.00
... Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Thromboembolism - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Thromboembolism (Cardiovascular) The guide covers the ...
July 2020
128 pages
Warts - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Warts (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Warts and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
112 pages
Post-Operative Pain - Pipeline Review, H2 2020
US$ 2,000.00
... . The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
302 pages
Typhoid Fever - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
53 pages
Hidradenitis Suppurativa - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hidradenitis Suppurativa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Hidradenitis Suppurativa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
251 pages
Hypoglycemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypoglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
87 pages
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2020
US$ 2,000.00
... Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngitis (Common Cold) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
46 pages
Bacterial Vaginosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Bacterial Vaginosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Vaginosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
75 pages
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2020
US$ 2,000.00
... . The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
97 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
152 pages
Cholera - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
62 pages
Dilated Cardiomyopathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Dilated Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Dilated Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
66 pages
House Dust Mite Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The House Dust Mite Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for House Dust Mite Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
61 pages
Insulin Resistance - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
52 pages
Left Ventricular Dysfunction - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Left Ventricular Dysfunction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Left Ventricular Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
48 pages
Plague - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Plague (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Plague and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
66 pages
Primary Sclerosing Cholangitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Primary Sclerosing Cholangitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Primary Sclerosing Cholangitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
150 pages
Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Venous Leg Ulcers (Crural Ulcer) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Venous Leg Ulcers (Crural Ulcer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
75 pages
Down Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Down Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Down Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
84 pages
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Functional (Non Ulcer) Dyspepsia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
36 pages
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
359 pages
Colitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
116 pages
Tourette Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... . The Tourette Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Tourette syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
74 pages
Ischemia Reperfusion Injury - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ischemia Reperfusion Injury (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ischemia Reperfusion Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
197 pages
Secondary Hyperparathyroidism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Secondary Hyperparathyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Secondary Hyperparathyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
63 pages
Sedation - Pipeline Review, H2 2020
US$ 2,000.00
... . The Sedation (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Sedation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
62 pages
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2020
US$ 2,000.00
... Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
83 pages
Community Acquired Pneumonia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Community Acquired Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
170 pages
